Skip to main content

Aceragen, Inc.

ACGNDelisted Aug 16, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000861838

Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Aceragen, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ACGN: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3432−2
Shares3.48M3.23M−246.3K (−7.1%)
Value$1.30M$1.13M−$170.2K (−13.1%)

New holders (5)

Institutions that held Aceragen, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ACGN in Q4 2022
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC19,294$6.75K0.00%
Cambridge Investment Research Advisors, Inc.10,806$4.00K0.00%
FMR LLC111$390.00%
NewSquare Capital LLC80$280.00%
Simplex Trading, LLC2,274$00.00%

Sold out (7)

Institutions that held Aceragen, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ACGN in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Millennium Management LLC82,472$31.0K
Virtu Financial LLC49,876$19.0K
Bryn Mawr Trust Co32,692$12.0K
Assenagon Asset Management S.A.27,784$10.0K
Susquehanna International Group, LLP14,432$5.00K
Y-Intercept (Hong Kong) Ltd10,082$3.78K
Northwestern Mutual Wealth Management Co2,500$1.00K